Cargando…
Gastric inhibitory polypeptide receptor antagonist, SKL‐14959, suppressed body weight gain on diet‐induced obesity mice
OBJECTIVE: Gastric inhibitory polypeptide plays a role in glucose and lipid metabolism and is associated with obesity and insulin resistance. The objective of this study is to confirm the anti‐obesity effects of the gastric inhibitory polypeptide receptor antagonist, SKL‐14959, on diet‐induced obesi...
Autores principales: | Nakamura, T., Tanimoto, H., Mizuno, Y., Okamoto, M., Takeuchi, M., Tsubamoto, Y., Noda, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893465/ https://www.ncbi.nlm.nih.gov/pubmed/29670757 http://dx.doi.org/10.1002/osp4.164 |
Ejemplares similares
-
GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice
por: Nakamura, Takashi, et al.
Publicado: (2021) -
SKL1 Is Essential for Chloroplast Development in Arabidopsis
por: Xu, Huimin, et al.
Publicado: (2018) -
Glucose‐dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet‐fed mice
por: Boer, Geke Aline, et al.
Publicado: (2022) -
Regulation of Drought and Salt Tolerance by OsSKL2 and OsASR1 in Rice
por: Jiang, Yingli, et al.
Publicado: (2022) -
Failure Analysis of Tension Clamps (SKL15) Used in Serviced Urban Railway Tracks: Numerical Analyses and Experiments
por: Choi, Jung-Youl, et al.
Publicado: (2022)